⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Icarus Therapeutics and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Icarus Therapeutics
↗San Diego, USA
Icarus Therapeutics is a global TechBio company specializing in clinical trial automation software. Their platform, often referred to as a 'NextGen' clinical trials optimization platform, utilizes AI and machine learning to streamline patient enrollment, improve trial diversity, and reduce the time and cost associated with clinical research. The company aims to act as a 'central nervous system' for clinical trial recruitment by matching patients directly with sponsors.
The company operates with a focus on public health and health equity, leveraging expertise from epidemiologists and software engineers. They are associated with JLABS (Johnson & Johnson Innovation) and have participated in programs such as NVIDIA Inception and Startup Health. Their services also include consulting for biotech and pharmaceutical companies regarding clinical trial optimization and data management.
CLASSIFICATION
Company Type:Digital Health
Therapeutic Areas:
Industry:Digital Health
Sub-Industry:Clinical Trial Automation / TechBio
SIZE & FINANCIALS
Employees:1-50
Ownership:private
Status:operating
FUNDING
Stage:Seed
PIPELINE
Stage:N/A
Lead Drug Stage:N/A
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:JLABS (Johnson & Johnson Innovation), NVIDIA Inception Program, Startup Health, ARPA-H Customer Experience Hub
COMPETITION
Position:Emerging
LEADERSHIP
Key Executives:
Nate Hughes - Founder and CEO
Scientific Founders:Nate Hughes, Pavan Bachireddy
LINKS
Website:icarustx.ai
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Icarus Therapeutics. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.